miRNA-218/FANCI is associated with metastasis and poor prognosis in lung adenocarcinoma: a bioinformatics analysis

miRNA-218/FANCI is associated with metastasis and poor prognosis in lung adenocarcinoma: a bioinformatics analysis

Background: In this study, tumor microarray analysis was used to screen the key messenger RNAs (mRNAs) and microRNAs related to the progression of lung adenocarcinoma (LUAD), in order to provide a theoretical basis for early diagnosis, therapeutic targets, and prognosis evaluation of patients with L...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of translational medicine 2021-08, Vol.9 (16), p.1298-1298, Article 1298
Hauptverfasser: Ye, Guanchao, Liu, Yafei, Huang, Lan, Zhang, Chunyang, Sheng, Yinliang, Wu, Bin, Wu, Chunli, Qi, Yu
Format: Artikel
Sprache:eng
Schlagworte:
Life Sciences & Biomedicine
Medicine, Research & Experimental
Oncology
Original
Research & Experimental Medicine
Science & Technology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1298
container_issue 16
container_start_page 1298
container_title Annals of translational medicine
container_volume 9
creator Ye, Guanchao
Liu, Yafei
Huang, Lan
Zhang, Chunyang
Sheng, Yinliang
Wu, Bin
Wu, Chunli
Qi, Yu
description Background: In this study, tumor microarray analysis was used to screen the key messenger RNAs (mRNAs) and microRNAs related to the progression of lung adenocarcinoma (LUAD), in order to provide a theoretical basis for early diagnosis, therapeutic targets, and prognosis evaluation of patients with LUAD. Methods: The mRNA and miRNA expression datasets came from the Gene Expression Omnibus (GEO) project database. Differentially expressed genes (DEGs) and microRNAs (DEMs) between LUAD tissues and adjacent lung tissue were obtained using GEO2R. The Search Tool for the Retrieval of Interacting Genes website was also employed to construct and visualize the interactions of overlapped DEGs. The overall survival of DEMs was investigated using the Kaplan-Meier plotter. The TargetScan website (http://www.targetscan.org/) was used to verify the relationship between FA Complementation Group I (FANCI) and the expression of miRNA-218 (miR-218). The expression of FANCI was verified using the GEO and Human Protein Atlas databases, as well as Real Time Quantitative PCR using our own samples. Next, we analyzed the relationship between the expression of FANCI and the clinicopathological characteristics as well as the prognosis of patients with LUAD. We also explored whether the FANCI was related to immune cell infiltration in LUAD. Results: FANCI was identified as a hub gene and associated with poor OS. We found that miR-218 negatively regulates FANCI mRNA expression. At the mRNA expression and protein level, FANCI was more highly expressed in LUAD tissues. The expression of FANCI in LUAD was related to tumor size (chi 2=13.96, P
doi_str_mv 10.21037/atm-21-3823
format Article
fullrecord <record><control><sourceid>proquest_webof</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8422123</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2574384449</sourcerecordid><originalsourceid>FETCH-LOGICAL-c314t-6caefa49851df1717f1aa8e389b4527ab0fc9a86c22d9da26911d440483cff2a3</originalsourceid><addsrcrecordid>eNqNkc1LHTEUxYO0VLHuupYshTo1X_Mm00XhMdRWEAulXYc7meQZmUmeSUbxv2-mTx92Vwjkkvs75yY5CH2g5BOjhDcXkKeK0YpLxg_QEeOkrmrJ2zev6kN0ktIdIYQy2nJC3qFDLmrOBK-PUJzcz5t1sZAXl-ub7gq7hCGloB1kM-BHl2_xZDKkspaWH_A2hIi3MWx8WI6cx-PsNxgG44OGqJ0PE3zGgHsXnLchTpCdXrQwPhXFe_TWwpjMyfN-jH5ffv3Vfa-uf3y76tbXleZU5GqlwVgQrazpYGlDG0sBpOGy7UXNGuiJ1S3IlWZsaAdgq5bSQQgiJNfWMuDH6MvOdzv3kxm08TnCqLbRTRCfVACn_u14d6s24UFJwRhlvBicPRvEcD-blNXkkjbjCN6EOSlWN4JLIURb0PMdqmNIKRq7H0OJ-puUKkmVSi1JFfz09dX28EsuBZA74NH0wSbtjNdmj5Usy2vL-HpJlXculx8Ovguzz0X68f-l_A-FSrFl</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2574384449</pqid></control><display><type>article</type><title>miRNA-218/FANCI is associated with metastasis and poor prognosis in lung adenocarcinoma: a bioinformatics analysis</title><source>Open Access: PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Ye, Guanchao ; Liu, Yafei ; Huang, Lan ; Zhang, Chunyang ; Sheng, Yinliang ; Wu, Bin ; Wu, Chunli ; Qi, Yu</creator><creatorcontrib>Ye, Guanchao ; Liu, Yafei ; Huang, Lan ; Zhang, Chunyang ; Sheng, Yinliang ; Wu, Bin ; Wu, Chunli ; Qi, Yu</creatorcontrib><description>Background: In this study, tumor microarray analysis was used to screen the key messenger RNAs (mRNAs) and microRNAs related to the progression of lung adenocarcinoma (LUAD), in order to provide a theoretical basis for early diagnosis, therapeutic targets, and prognosis evaluation of patients with LUAD. Methods: The mRNA and miRNA expression datasets came from the Gene Expression Omnibus (GEO) project database. Differentially expressed genes (DEGs) and microRNAs (DEMs) between LUAD tissues and adjacent lung tissue were obtained using GEO2R. The Search Tool for the Retrieval of Interacting Genes website was also employed to construct and visualize the interactions of overlapped DEGs. The overall survival of DEMs was investigated using the Kaplan-Meier plotter. The TargetScan website (http://www.targetscan.org/) was used to verify the relationship between FA Complementation Group I (FANCI) and the expression of miRNA-218 (miR-218). The expression of FANCI was verified using the GEO and Human Protein Atlas databases, as well as Real Time Quantitative PCR using our own samples. Next, we analyzed the relationship between the expression of FANCI and the clinicopathological characteristics as well as the prognosis of patients with LUAD. We also explored whether the FANCI was related to immune cell infiltration in LUAD. Results: FANCI was identified as a hub gene and associated with poor OS. We found that miR-218 negatively regulates FANCI mRNA expression. At the mRNA expression and protein level, FANCI was more highly expressed in LUAD tissues. The expression of FANCI in LUAD was related to tumor size (chi 2=13.96, P&lt;0.001), lymphatic metastasis (chi 2=3.88, P&lt;0.05), distant metastasis (chi 2=45.39, P&lt;0.001), and stage (chi 2=11.03, P&lt;0.05). In addition, the Cox regression model found that FANCI mRNA expression was an independent predictive factor of patient survival (P&lt;0.05). FANCI expression was both weakly related to B cells and neutrophil infiltration in LUAD. Conclusions: miR-218 may negatively regulate FANCI, and FANCI could promote metastasis via extracellular matrix (ECM) receptor interaction, leading to poor prognosis of LUAD. FANCI may be a key gene to the determine metastasis and poor prognosis in patients with LUAD. Changes in the immune microenvironment may be the mechanism through which FANCI leads to poor prognosis of LUAD.</description><identifier>ISSN: 2305-5839</identifier><identifier>EISSN: 2305-5839</identifier><identifier>DOI: 10.21037/atm-21-3823</identifier><identifier>PMID: 34532435</identifier><language>eng</language><publisher>SHATIN: AME PUBLISHING COMPANY</publisher><subject>Life Sciences &amp; Biomedicine ; Medicine, Research &amp; Experimental ; Oncology ; Original ; Research &amp; Experimental Medicine ; Science &amp; Technology</subject><ispartof>Annals of translational medicine, 2021-08, Vol.9 (16), p.1298-1298, Article 1298</ispartof><rights>2021 Annals of Translational Medicine. All rights reserved.</rights><rights>2021 Annals of Translational Medicine. All rights reserved. 2021 Annals of Translational Medicine.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>7</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000691257500013</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c314t-6caefa49851df1717f1aa8e389b4527ab0fc9a86c22d9da26911d440483cff2a3</citedby><cites>FETCH-LOGICAL-c314t-6caefa49851df1717f1aa8e389b4527ab0fc9a86c22d9da26911d440483cff2a3</cites><orcidid>0000-0001-9204-6548 ; 0000-0002-8755-4238 ; 0000-0002-8854-7670 ; 0000-0001-9679-9790 ; 0000-0002-2080-3869 ; 0000-0003-4339-5922 ; 0000-0001-6794-5760 ; 0000-0002-8318-8947</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422123/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422123/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34532435$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ye, Guanchao</creatorcontrib><creatorcontrib>Liu, Yafei</creatorcontrib><creatorcontrib>Huang, Lan</creatorcontrib><creatorcontrib>Zhang, Chunyang</creatorcontrib><creatorcontrib>Sheng, Yinliang</creatorcontrib><creatorcontrib>Wu, Bin</creatorcontrib><creatorcontrib>Wu, Chunli</creatorcontrib><creatorcontrib>Qi, Yu</creatorcontrib><title>miRNA-218/FANCI is associated with metastasis and poor prognosis in lung adenocarcinoma: a bioinformatics analysis</title><title>Annals of translational medicine</title><addtitle>ANN TRANSL MED</addtitle><addtitle>Ann Transl Med</addtitle><description>Background: In this study, tumor microarray analysis was used to screen the key messenger RNAs (mRNAs) and microRNAs related to the progression of lung adenocarcinoma (LUAD), in order to provide a theoretical basis for early diagnosis, therapeutic targets, and prognosis evaluation of patients with LUAD. Methods: The mRNA and miRNA expression datasets came from the Gene Expression Omnibus (GEO) project database. Differentially expressed genes (DEGs) and microRNAs (DEMs) between LUAD tissues and adjacent lung tissue were obtained using GEO2R. The Search Tool for the Retrieval of Interacting Genes website was also employed to construct and visualize the interactions of overlapped DEGs. The overall survival of DEMs was investigated using the Kaplan-Meier plotter. The TargetScan website (http://www.targetscan.org/) was used to verify the relationship between FA Complementation Group I (FANCI) and the expression of miRNA-218 (miR-218). The expression of FANCI was verified using the GEO and Human Protein Atlas databases, as well as Real Time Quantitative PCR using our own samples. Next, we analyzed the relationship between the expression of FANCI and the clinicopathological characteristics as well as the prognosis of patients with LUAD. We also explored whether the FANCI was related to immune cell infiltration in LUAD. Results: FANCI was identified as a hub gene and associated with poor OS. We found that miR-218 negatively regulates FANCI mRNA expression. At the mRNA expression and protein level, FANCI was more highly expressed in LUAD tissues. The expression of FANCI in LUAD was related to tumor size (chi 2=13.96, P&lt;0.001), lymphatic metastasis (chi 2=3.88, P&lt;0.05), distant metastasis (chi 2=45.39, P&lt;0.001), and stage (chi 2=11.03, P&lt;0.05). In addition, the Cox regression model found that FANCI mRNA expression was an independent predictive factor of patient survival (P&lt;0.05). FANCI expression was both weakly related to B cells and neutrophil infiltration in LUAD. Conclusions: miR-218 may negatively regulate FANCI, and FANCI could promote metastasis via extracellular matrix (ECM) receptor interaction, leading to poor prognosis of LUAD. FANCI may be a key gene to the determine metastasis and poor prognosis in patients with LUAD. Changes in the immune microenvironment may be the mechanism through which FANCI leads to poor prognosis of LUAD.</description><subject>Life Sciences &amp; Biomedicine</subject><subject>Medicine, Research &amp; Experimental</subject><subject>Oncology</subject><subject>Original</subject><subject>Research &amp; Experimental Medicine</subject><subject>Science &amp; Technology</subject><issn>2305-5839</issn><issn>2305-5839</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><recordid>eNqNkc1LHTEUxYO0VLHuupYshTo1X_Mm00XhMdRWEAulXYc7meQZmUmeSUbxv2-mTx92Vwjkkvs75yY5CH2g5BOjhDcXkKeK0YpLxg_QEeOkrmrJ2zev6kN0ktIdIYQy2nJC3qFDLmrOBK-PUJzcz5t1sZAXl-ub7gq7hCGloB1kM-BHl2_xZDKkspaWH_A2hIi3MWx8WI6cx-PsNxgG44OGqJ0PE3zGgHsXnLchTpCdXrQwPhXFe_TWwpjMyfN-jH5ffv3Vfa-uf3y76tbXleZU5GqlwVgQrazpYGlDG0sBpOGy7UXNGuiJ1S3IlWZsaAdgq5bSQQgiJNfWMuDH6MvOdzv3kxm08TnCqLbRTRCfVACn_u14d6s24UFJwRhlvBicPRvEcD-blNXkkjbjCN6EOSlWN4JLIURb0PMdqmNIKRq7H0OJ-puUKkmVSi1JFfz09dX28EsuBZA74NH0wSbtjNdmj5Usy2vL-HpJlXculx8Ovguzz0X68f-l_A-FSrFl</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Ye, Guanchao</creator><creator>Liu, Yafei</creator><creator>Huang, Lan</creator><creator>Zhang, Chunyang</creator><creator>Sheng, Yinliang</creator><creator>Wu, Bin</creator><creator>Wu, Chunli</creator><creator>Qi, Yu</creator><general>AME PUBLISHING COMPANY</general><general>AME Publishing Company</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9204-6548</orcidid><orcidid>https://orcid.org/0000-0002-8755-4238</orcidid><orcidid>https://orcid.org/0000-0002-8854-7670</orcidid><orcidid>https://orcid.org/0000-0001-9679-9790</orcidid><orcidid>https://orcid.org/0000-0002-2080-3869</orcidid><orcidid>https://orcid.org/0000-0003-4339-5922</orcidid><orcidid>https://orcid.org/0000-0001-6794-5760</orcidid><orcidid>https://orcid.org/0000-0002-8318-8947</orcidid></search><sort><creationdate>20210801</creationdate><title>miRNA-218/FANCI is associated with metastasis and poor prognosis in lung adenocarcinoma: a bioinformatics analysis</title><author>Ye, Guanchao ; Liu, Yafei ; Huang, Lan ; Zhang, Chunyang ; Sheng, Yinliang ; Wu, Bin ; Wu, Chunli ; Qi, Yu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c314t-6caefa49851df1717f1aa8e389b4527ab0fc9a86c22d9da26911d440483cff2a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Life Sciences &amp; Biomedicine</topic><topic>Medicine, Research &amp; Experimental</topic><topic>Oncology</topic><topic>Original</topic><topic>Research &amp; Experimental Medicine</topic><topic>Science &amp; Technology</topic><toplevel>online_resources</toplevel><creatorcontrib>Ye, Guanchao</creatorcontrib><creatorcontrib>Liu, Yafei</creatorcontrib><creatorcontrib>Huang, Lan</creatorcontrib><creatorcontrib>Zhang, Chunyang</creatorcontrib><creatorcontrib>Sheng, Yinliang</creatorcontrib><creatorcontrib>Wu, Bin</creatorcontrib><creatorcontrib>Wu, Chunli</creatorcontrib><creatorcontrib>Qi, Yu</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of translational medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ye, Guanchao</au><au>Liu, Yafei</au><au>Huang, Lan</au><au>Zhang, Chunyang</au><au>Sheng, Yinliang</au><au>Wu, Bin</au><au>Wu, Chunli</au><au>Qi, Yu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>miRNA-218/FANCI is associated with metastasis and poor prognosis in lung adenocarcinoma: a bioinformatics analysis</atitle><jtitle>Annals of translational medicine</jtitle><stitle>ANN TRANSL MED</stitle><addtitle>Ann Transl Med</addtitle><date>2021-08-01</date><risdate>2021</risdate><volume>9</volume><issue>16</issue><spage>1298</spage><epage>1298</epage><pages>1298-1298</pages><artnum>1298</artnum><issn>2305-5839</issn><eissn>2305-5839</eissn><abstract>Background: In this study, tumor microarray analysis was used to screen the key messenger RNAs (mRNAs) and microRNAs related to the progression of lung adenocarcinoma (LUAD), in order to provide a theoretical basis for early diagnosis, therapeutic targets, and prognosis evaluation of patients with LUAD. Methods: The mRNA and miRNA expression datasets came from the Gene Expression Omnibus (GEO) project database. Differentially expressed genes (DEGs) and microRNAs (DEMs) between LUAD tissues and adjacent lung tissue were obtained using GEO2R. The Search Tool for the Retrieval of Interacting Genes website was also employed to construct and visualize the interactions of overlapped DEGs. The overall survival of DEMs was investigated using the Kaplan-Meier plotter. The TargetScan website (http://www.targetscan.org/) was used to verify the relationship between FA Complementation Group I (FANCI) and the expression of miRNA-218 (miR-218). The expression of FANCI was verified using the GEO and Human Protein Atlas databases, as well as Real Time Quantitative PCR using our own samples. Next, we analyzed the relationship between the expression of FANCI and the clinicopathological characteristics as well as the prognosis of patients with LUAD. We also explored whether the FANCI was related to immune cell infiltration in LUAD. Results: FANCI was identified as a hub gene and associated with poor OS. We found that miR-218 negatively regulates FANCI mRNA expression. At the mRNA expression and protein level, FANCI was more highly expressed in LUAD tissues. The expression of FANCI in LUAD was related to tumor size (chi 2=13.96, P&lt;0.001), lymphatic metastasis (chi 2=3.88, P&lt;0.05), distant metastasis (chi 2=45.39, P&lt;0.001), and stage (chi 2=11.03, P&lt;0.05). In addition, the Cox regression model found that FANCI mRNA expression was an independent predictive factor of patient survival (P&lt;0.05). FANCI expression was both weakly related to B cells and neutrophil infiltration in LUAD. Conclusions: miR-218 may negatively regulate FANCI, and FANCI could promote metastasis via extracellular matrix (ECM) receptor interaction, leading to poor prognosis of LUAD. FANCI may be a key gene to the determine metastasis and poor prognosis in patients with LUAD. Changes in the immune microenvironment may be the mechanism through which FANCI leads to poor prognosis of LUAD.</abstract><cop>SHATIN</cop><pub>AME PUBLISHING COMPANY</pub><pmid>34532435</pmid><doi>10.21037/atm-21-3823</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0001-9204-6548</orcidid><orcidid>https://orcid.org/0000-0002-8755-4238</orcidid><orcidid>https://orcid.org/0000-0002-8854-7670</orcidid><orcidid>https://orcid.org/0000-0001-9679-9790</orcidid><orcidid>https://orcid.org/0000-0002-2080-3869</orcidid><orcidid>https://orcid.org/0000-0003-4339-5922</orcidid><orcidid>https://orcid.org/0000-0001-6794-5760</orcidid><orcidid>https://orcid.org/0000-0002-8318-8947</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2305-5839
ispartof Annals of translational medicine, 2021-08, Vol.9 (16), p.1298-1298, Article 1298
issn 2305-5839
2305-5839
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8422123
source Open Access: PubMed Central; EZB Electronic Journals Library
subjects Life Sciences & Biomedicine
Medicine, Research & Experimental
Oncology
Original
Research & Experimental Medicine
Science & Technology
title miRNA-218/FANCI is associated with metastasis and poor prognosis in lung adenocarcinoma: a bioinformatics analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T16%3A29%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=miRNA-218/FANCI%20is%20associated%20with%20metastasis%20and%20poor%20prognosis%20in%20lung%20adenocarcinoma:%20a%20bioinformatics%20analysis&rft.jtitle=Annals%20of%20translational%20medicine&rft.au=Ye,%20Guanchao&rft.date=2021-08-01&rft.volume=9&rft.issue=16&rft.spage=1298&rft.epage=1298&rft.pages=1298-1298&rft.artnum=1298&rft.issn=2305-5839&rft.eissn=2305-5839&rft_id=info:doi/10.21037/atm-21-3823&rft_dat=%3Cproquest_webof%3E2574384449%3C/proquest_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2574384449&rft_id=info:pmid/34532435&rfr_iscdi=true